CHO Pharma Company Description

CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs.

It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia.

The company was founded in 2012 and is based in Taipei City, Taiwan.

CHO Pharma, Inc.

Country	Taiwan
Founded	2012
Industry	Biotechnology
Sector	Healthcare
CEO	Chung-Yi Wu

Contact Details

Address: Building C Taipei, 115202 Taiwan
Phone	886 2 2655 8059
Website	chopharma.com

Stock Details

Ticker Symbol	6586
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
SIC Code	2834

Key Executives

Name	Position
Dr. Chung-Yi Wu Ph.D.	President, Chief Executive Officer, GM and Director
Sammi Chou	Chief Financial Officer
Dr. Ling-Mei Wang	Vice President of Operation
Yibei Zhou	Accounting Supervisor